Showing results (1401-1410 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|May 31, 2022
Prevalence of BRCA1 and BRCA2 Germline Mutations in Patients of African Descent with Early-Onset and Familial Colombian Breast CancerElizabeth Vargas, Robert de Deugd, Victoria E Villegas, et al.
The Oncologist|June 7, 2022
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant MesotheliomaYutaka Fujiwara, Yasuo Takahashi, Morihito Okada, et al.
The Oncologist|June 29, 2022
Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade TreatmentKimberly Loo, Hannah L Kalvin, Katherine S Panageas, et al.
The Oncologist|June 27, 2022
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS StudySatoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, et al.
The Oncologist|June 2, 2019
Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung CancerFlorian J Fintelmann, Fabian M Troschel, Martin W Kuklinski, et al.
The Oncologist|July 19, 2022
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare NetworkDora Dias-Santagata, Rebecca S Heist, Adam Z Bard, et al.
The Oncologist|May 25, 2010
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choicesYu-Ning Wong, Olivia Hamilton, Brian Egleston, et al.
The Oncologist|October 29, 2010
Nonmyeloablative allogeneic stem cell transplantation for nasopharyngeal carcinomaWhay K Chia, Who W Wang, Wan T Lim, et al.
The Oncologist|August 26, 2010
Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trialDavid Cameron, Michelle Casey, Cristina Oliva, et al.
The Oncologist|July 22, 2010
Conditional survival among cancer patients in the United StatesRay M Merrill, Bradley D Hunter
Pageof 570